Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck
- Status
- UNKNOWN
- Phase
- N/A
DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Develop and Test the 'Multi-Faced Continuous Exercise Program' in Operable Head and Neck Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC
- Status
- WITHDRAWN
- Phase
- PHASE1
RTX-224 Monotherapy in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
- Status
- RECRUITING
- Phase
- N/A
The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1